These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1086363)

  • 1. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 2. The blocking effect of conditioned media from tumour cell cultures on the lysis of target cells by immune lymphocytes and macrophages.
    Lavrovsky VA; Tikhonov VJ; Rubzov NB; Razvorotnev VA
    Folia Biol (Praha); 1976; 22(2):101-7. PubMed ID: 1278566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphocytes. Roles in cellular immunity and humoral immunity].
    Golovtchenko AM; Raichvarg D
    Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.
    Kurata S; Tsuchiya T; Norimura T; Yamashita U
    J Immunol; 1983 Jan; 130(1):496-500. PubMed ID: 6600195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O
    Transplant Proc; 1977 Mar; 9(1):1153-5. PubMed ID: 194369
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.
    Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD
    J Med; 1974; 5(1):92-7. PubMed ID: 4275505
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammary tumor heterogeneity.
    Heppner GH; Loveless SE; Miller FR; Mahoney KH; Fulton AM
    Symp Fundam Cancer Res; 1983; 36():209-21. PubMed ID: 6382505
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
    Ptak W
    Allerg Immunol (Leipz); 1973; 19(2-4):290-6. PubMed ID: 4375939
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.
    Haskill JS; Key M; Radov LA; Parthenais E; Korn JH; Fett JW; Yamamura Y; DeLustro F; Vesley J; Gant G
    J Reticuloendothel Soc; 1979 Oct; 26(4):417-25. PubMed ID: 316009
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regulator antibodies and suppressive cells: interactions in the helper reaction].
    Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):431-43. PubMed ID: 300607
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macrophages as target cells in in vitro experiments on delayed hypersensitivity].
    Smirnova MN; Bazanova EA
    Vestn Akad Med Nauk SSSR; 1974; (11):14-6. PubMed ID: 4450717
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of humoral factors in the initiation of in vitro primary immune responses. IV. Are macrophages the adherent cell type required for cell cooperation.
    Watson J; Thoman M; Ralph P; Trenkner E
    J Immunol; 1974 May; 112(5):1873-83. PubMed ID: 4131877
    [No Abstract]   [Full Text] [Related]  

  • 19. A new method for cytotoxicity in vitro test of cellular immunity.
    Kitano M; Ujhazy V
    Bull Chest Dis Res Inst Kyoto Univ; 1973 Mar; 6(2):93-102. PubMed ID: 4730518
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.